Abbott Receives CE Mark and Canadian Approval for Next-Generation TriClip Tricuspid Valve Repair Device
Abbott Receives CE Mark and Canadian Approval for Next-Generation TriClip Tricuspid Valve Repair Device New enhancements to first-of-its-kind device uniquely developed for the difficult-to-treat tricuspid valve The new generation Abbott TriClip G4 device has gained European and Canadian approvals for transcatheter tricuspid valve repair (TTVR). The device is an iteration of the successful MitraClip device used for transcatheter mitral valve repairs. April 8, 2021 — Abbott today announced it has received European CE mark and Health Canada authorization this week for its next-generation T...
Source: dicardiology.com